Hi,
I'm about to do several two-sample mendelian randomisation analysis. I'm in doubt if it is important that both exposure and outcome dataset are from the same assembly genome (hg19/hg38). Also, I'm running several MR with the same outcome data, but different exposure datasets - is it important that every analysis are on the same build or is not important as the analysis are using rsIDs?
Thank you in advance for any input to this.
•
written
by
lag •
1 answer
I’m interested in this issue as well and generally agree—if you’re working solely with rsIDs and not using any tools that require genomic positions, it might not be necessary. However, I’m not entirely certain and would welcome insights from other experts.
Log in to answer this question.
-
Obtaining Infinium Methylation450K manifest for hg38
written by elisheva
-
Pre-imputation checks using 1000G data (hg19) for a hg38 VCF
written by graeme.thorn
-
Picard LiftOver rejecting all Variants
written by nanodano •
-
Mendelian Randomisation with GTEx data
written by ciarancampbell •
-
Meta-analysis of two datasets.
written by parveenkayenat •
-
Mendelian randomisation (MR) and MHC locus
written by rednalf
-
Mendelian randomisation and covariates
written by rednalf
-
Is there any problem on Mendelian Randomization analysis with binary exposure and outcome?
written by sjunlee89 •
-
FeatureCounts on HG38
written by elb
-
Liftover dbSNP IDs
written by Arko •
